BlinkLab

Blinklab Commences Partnership with Turning Pointe Autism Foundation for Clinical Study in Children with Autism in the US

BlinkLab Limited (ASX:BB1) (“BlinkLab” or the “Company”), an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for autism, today announced that it initiated a clinical study in partnership with US based Turning Pointe Autism Foundation. The study will enroll up to one hundred children previously diagnosed with autism and one hundred children without an autism diagnosis. The data obtained during the course of this collaboration will be used to finalize the data collection and processing algorithms as well as AI/ML models ahead of the FDA registrational study expected to start in the second half of 2024.


Highlights

  • Strategic partnership initiated with US Based Turning Pointe Autism Foundation, to conduct a clinical study using AI-powered diagnostic tools developed for autism.
  • The study will involve up to two hundred children aiming to finalize the artificial intelligence/machine learning (“AI/ML”) algorithms and models for a larger FDA registration study planned for the second half of 2024.
  • This study aligns with regulatory preparations, setting the stage for an FDA registrational study.
  • The collaboration agreement ensures that any intellectual property developed as a direct result of the partnership will be owned by BlinkLab.
Founded in 2007, Turning Pointe Autism Foundation in Naperville, Illinois, was created to meet the specific and unique needs of students learning with autism. It offers individuals with autism between 5 to 22 years of age best practice programs to support their growth, development, and employment. To date, Turning Pointe’s commitment has had an impact on enhancing independence, communication, and social interactions among hundreds of children, teens, and adults. This collaboration between Turning Pointe and BlinkLab supports its vision to remain at the intersection of hope and innovation.

BlinkLab is proud to bring its innovative neurobehavioral tests to Turning Pointe’s programs. These tests, which can be easily administered via smartphone, are a game-changer in making diagnostic tools more accessible. BlinkLab’s initial focus will be on a pilot program involving students from Turning Pointe aimed at refining and improving the data collection and processing algorithms as well as our AI/Machine Learning models.

Henk-Jan Boele, CEO of BlinkLab commented:

“Our partnership with Turning Pointe is more than just collaboration. It is a major step toward fulfilling our mission to make well-established neurobehavioral testing clinically accessible and efficient. Turning Pointe’s dedication to quality education and support aligns perfectly with our goal of leveraging cutting-edge technology to better understand and assist individuals with autism. We are very excited about the possibilities that this collaboration offers for the advancement of autism diagnosis and care.”

Brian Leedman, Chairman of BlinkLab commented:

“I am excited to see that our first substantive news following our listing a few weeks ago is a collaboration with this prestigious group in the field of autism research in children. I anticipate many more important announcements such as these as we get closer to the commencement of our FDA registration study later this year”.

Study design and experimental setup

Neurobehavioral testing will be performed using the smartphone-based platform developed by BlinkLab. The tests will include general measurement of spontaneous and stimulus-evoked postural, head, facial, and vocal responses along with specific neurometric tests, including the acoustic startle response, prepulse inhibition, long-term habituation, and short-term habituation. Up to two hundred children will participate in the study. During the 15-minute smartphone evaluations, the children will watch an audio-normalized movie while the trials containing the auditory stimuli will be delivered via headphones. For each trial, computer vision algorithms will be used to track and record the position of the participant’s facial landmarks over time. The study will be performed in accordance with relevant guidelines and regulations and study protocol was reviewed and approved by the institutional review board of Princeton University (#13943) and Turning Pointe Autism Foundation.


Click here for the full ASX Release

This article includes content from Blinklab Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.


BB1:AU
BlinkLab Limited

BlinkLab Limited Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

The Conversation (0)
BlinkLab Limited

BlinkLab Limited


Keep reading...Show less

Revolutionising Mental Health Care Through Mobile Solutions

US Autism Diagnostic Study Commences with First Child Tested

US Autism Diagnostic Study Commences with First Child Tested

BlinkLab Limited (BB1:AU) has announced US Autism Diagnostic Study Commences with First Child Tested

Download the PDF here.

Robotic hand and human hand reaching out to touch glowing brain.

ASX AI Stocks: 5 Biggest Companies

Artificial intelligence (AI) continues to evolve and advance rapidly, becoming increasingly integrated in the automation of everyday life and a focal point of growth in the technology sector.

According to a September 2023 report from IDC on worldwide AI spending, Australia, along with Korea and India, is leading the Asia-Pacific region in spending on AI solutions; the three countries are also leading when it comes to AI adoption in the area. Spending in the region, excluding Japan and China, is expected to reach US$28.2 billion by 2027.

Although the AI market is relatively small in Australia, it’s growing. To help investors understand the options available, the Investing News Network used TradingView's stock screener to find the top AI stocks on ASX by market cap. All ASX AI stocks data was current as of April 7, 2025. companies whose businesses are focused mainly on AI were considered.

Keep reading...Show less
Hands holding a glowing AI circuit with digital network icons.

AI Market Update: Q1 2025 in Review

The first quarter of 2025 was dynamic and often volatile for the tech sector. Initial optimism, fueled by investor enthusiasm after a strong 2024, quickly gave way to economic headwinds and market anxieties.

Concerns over monetary policy, global trade tensions and individual company performances led to variations in tech stock valuations, with the Magnificent Seven ultimately experiencing losses by March.

However, Q1 also brought groundbreaking developments in artificial intelligence (AI), intense competition in the semiconductor industry and new developments in AI agents and robotics.

Keep reading...Show less
Man holding magnifying glass.

Tech 5: CoreWeave IPO Falls Short, OpenAI Close to Completing US$40 Billion Funding Round

This week brought a fresh set of challenges to the tech sector, beginning with an announcement from the US Bureau of Industry and Security on Tuesday (March 25) of new export restrictions targeting 80 companies across Asia and the Middle East, impacting some of Big Tech’s key customers.

Consumer confidence weakened, further dampening market sentiment.

This was evidenced by the release of the Conference Board’s Consumer Confidence Index report on Tuesday, and the University of Michigan’s consumer sentiment survey, released on Friday (March 28).

Keep reading...Show less
Hand holding an AI chip.

Global AI Stocks: 9 Biggest Companies in 2025

As the artificial intelligence (AI) market continues to grow, there are many AI stocks for investors to choose from on top exchanges like the NASDAQ, TSX and ASX.

AI technology has made strong inroads into several key industries, including logistics, manufacturing, finance, healthcare, customer service and cybersecurity.

The technology has been around for a long time, but this current wave of buzz comes after the release of OpenAI’s ChatGPT, a generative AI platform. This intelligent chatbot shows how quickly generative AI is advancing, and it has led to many other major tech firms entering the space with their own generative AI offerings or including AI technology into their innovative products.

Keep reading...Show less
RocketBoots

RocketBoots Partners with Global POS Software Vendor to Drive Customer Markets Penetration

Artificial Intelligence software company, RocketBoots Limited (ASX:ROC) (RocketBoots or the Company), is pleased to announce the signing of a partnership agreement with global point-of-sale (POS) vendor, GEBIT Solutions GmbH (Gebit).

Keep reading...Show less
BlinkLab Limited

BlinkLab Limited Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

Latest Press Releases

Related News

×